tirzepatide glucagon Major physiological roles of GLP-1 and GIP. is acting as an The Science Behind Tirzepatide: GLP-1

In a post hoc analysis of SURPASS-4, tirzepatide treatment was associated with a significant reduction in composite renal outcome events (time to first occurrence of at least 40% decline in estimated glomerular filtration rate from baseline, end-stage renal disease, renal-related death, or incident macroalbuminuria) compared with treatment with insulin glargine (HR = 0.58

It has changed how we view weight loss and blood sugar control

J Biol Chem (1981) 256:65158

While patients typically experience efficient weight loss, they might feel lethargic and fatigued while taking the medication because of GI side effects and reduced calorie intake